Episode Details

Back to Episodes
Episode 158: ASCO GU 2022 PROpel Phase III olaparib and abiraterone in renal cancer

Episode 158: ASCO GU 2022 PROpel Phase III olaparib and abiraterone in renal cancer

Season 1 Episode 161 Published 4 years, 8 months ago
Description
Fred Saad describes the results of this trial.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us